Genetic Clues Make CAR T Therapy Safer
New research found genetic signals that help predict side effects from a cancer treatment.
Doctors use CAR T-cell therapy to fight certain cancers. The therapy, called Yescarta, has helped many patients. However, some patients have very serious side effects. Now, scientists found a way to predict who might get sick from the treatment.
Researchers looked at Yescarta's past clinical trials. They found genetic "red flags" in some patients. These genetic markers show who may have bad reactions to the therapy. This discovery means doctors can better choose treatment for patients.
This new information will help make future CAR T-cell treatments safer. Scientists can now design new therapies avoiding these risks. This makes CAR T-cell therapy a better option for more people fighting cancer.
Source: FierceBiotech
More from Biotech
